ReviewMiddle East journal of digestive diseases2018
Eradication of
Review in Middle East journal of digestive diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 39 citations in OpenAlex.
- Rech. f. & Esfand as adjunctive therapy for eradication: a randomized controlled trial.Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2025Trial
- Comparison of the Efficacy of 12-day Concomitant Quadruple Therapy versus 14-day High dose Dual Therapy as a First-lineThe Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2024Trial
- Molecular Characterization of Antimicrobial Resistance and Virulence Genotyping amongInfectious disorders drug targets · 2025Article
- An Update on Eradication ofMiddle East journal of digestive diseases · 2024Review
- Targeted delivery of a short antimicrobial peptide (CM11) against Helicobacter pylori gastric infection using concanavalin A-coated chitosan nanoparticles.Journal of materials science. Materials in medicine · 2023Article
- Evaluation ofAnnals of medicine and surgery (2012) · 2023Article
- Gastric troubles in Iran: The role of social and economic factors inHealth promotion perspectives · 2023Article
- A Population-Based Cross-sectional Study on the Prevalence and Associated Risk Factors ofMiddle East journal of digestive diseases · 2022Article
- Antibiotic resistance pattern ofJournal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2022Article
- Efficacy of 14-day concomitant quadruple therapy and 14-day high-dose dual therapy onGastroenterology and hepatology from bed to bench · 2022Article
- Prevalence ofMiddle East journal of digestive diseases · 2021Article
- Observational
- Formula Diet Alters the Ileal Metagenome and Transcriptome at Weaning and during the Postweaning Period in a Porcine Model.mSystems · 2020Article
- A Comparison between 10-day and 12-day Concomitant Regimens forMiddle East journal of digestive diseases · 2020Article
- Molecular Assessment of Resistance to Clarithromycin inBioMed research international · 2020Article
- Levofloxacin-containing triple therapy versus bismuth-based quadruple therapy as regimens for second line anti- Helicobacter pylori.Caspian journal of internal medicine · 2019Article
- Article
- Comparison of Levofloxacin-Based, 10-day Sequential Therapy with 14-day Quadruple Therapy forMiddle East journal of digestive diseases · 2018Article
- Helicobacter pylori and its relationship with variations of gut microbiota in asymptomatic children between 6 and 12 years.BMC research notes · 2018Article
- The Comparison of Levofloxacin- and Clarithromycin-Based Bismuth Quadruple Therapy Regimens inJournal of research in pharmacy practiceArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.